|
1
|
Schaue D and McBride WH: Opportunities and
challenges of radiotherapy for treating cancer. Nat Rev Clin Oncol.
12:527–540. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yerolatsite M, Torounidou N, Amylidi AL,
Rapti IC, Zarkavelis G, Kampletsas E and Voulgari PV: A Systematic
review of pneumonitis following treatment with immune checkpoint
inhibitors and radiotherapy. Biomedicines. 13:9462025. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tubiana M: Wilhelm conrad röntgen and the
discovery of X-rays. Bull Acad Natl Med. 180:97–108. 1996.(In
French). PubMed/NCBI
|
|
4
|
Babic RR, Stankovic Babic G, Babic SR and
Babic NR: 120 years since the discovery of X-Rays. Med Pregl.
69:323–330. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Klucznik KA, Ravkilde T, Skouboe S, Møller
DS, Hokland S, Keall P, Buus S, Bentzen L and Poulsen PR: Cone-beam
CT-based estimations of prostate motion and dose distortion during
radiotherapy. Phys Imaging Radiat Oncol. 35:1007982025. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lam MB, Landrum MB, McWilliams JM, Buzzee
B, Wright AA, Keating NL and Landon BE: Practice-level spending
variation for radiation treatment episodes among older adults with
cancer. JAMA Health Forum. 6:e2519522025. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hill RM, Fok M, Grundy G, Parsons JL and
Rocha S: The role of autophagy in hypoxia-induced radioresistance.
Radiother Oncol. 189:1099512023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang C, Song R, Yuan J, Hou G, Chu AL,
Huang Y, Xiao C, Chai T, Sun C and Liu Z: Exosome-Shuttled METTL14
From AML-Derived mesenchymal stem cells promotes the proliferation
and radioresistance in AML cells by stabilizing ROCK1 expression
via an m6A-IGF2BP3-dependent mechanism. Drug Dev Res.
86:e700252025. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luo H, Huang MF, Xu A, Wang D, Gingold JA,
Tu J, Wang R, Huo Z, Chiang YT, Tsai KL, et al: Mutant p53 confers
chemoresistance by activating KMT5B-mediated DNA repair pathway in
nasopharyngeal carcinoma. Cancer Lett. 625:2177362025. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng Y, Zhang L, Zhang Y, Xu Y, Zhou K,
Yang Z, Zhu W, Zhang Q, Cao J, Wang L and Jiao Y: NEDD4-mediated
endothelial-mesenchymal transition participates in
radiation-induced lung injury through the ATM signaling pathway.
Dose Response. 23:155932582513527262025. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qu Z, Shi L, Wang P, Zhao A, Zheng X and
Yin Q: Dual targeting of inflammatory and immune checkpoint
pathways to overcome radiotherapy resistance in esophageal squamous
cell carcinoma. J Inflamm Res. 18:9091–9106. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Porrazzo A, Cassandri M, D'Alessandro A,
Morciano P, Rota R, Marampon F and Cenci G: DNA repair in tumor
radioresistance: Insights from fruit flies genetics. Cell Oncol.
47:717–732. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mizushima N and Komatsu M: Autophagy:
Renovation of cells and tissues. Cell. 147:728–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cursaro I, Rossi S, Butini S, Gemma S,
Carullo G and Campiani G: A focus on natural autophagy modulators
as potential host-directed weapons against emerging and re-emerging
viruses. Med Res Rev. Jul 16–2025.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Parzych KR and Klionsky DJ: An overview of
autophagy: Morphology, mechanism, and regulation. Antioxid Redox
Signal. 20:460–473. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Debnath J, Gammoh N and Ryan KM: Autophagy
and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol.
24:560–575. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vafadar A, Tajbakhsh A,
Hosseinpour-Soleimani F, Savardshtaki A and Hashempur MH:
Phytochemical-mediated efferocytosis and autophagy in inflammation
control. Cell Death Discov. 10:4932024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feng X, Zhang H, Meng L, Song H, Zhou Q,
Qu C, Zhao P, Li Q, Zou C, Liu X and Zhang Z: Hypoxia-induced
acetylation of PAK1 enhances autophagy and promotes brain
tumorigenesis via phosphorylating ATG5. Autophagy. 17:723–742.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu S, Yao S, Yang H, Liu S and Wang Y:
Autophagy: Regulator of cell death. Cell Death Dis. 14:6482023.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martini-Stoica H, Xu Y, Ballabio A and
Zheng H: The autophagy-lysosomal pathway in neurodegeneration: A
TFEB perspective. Trends Neurosci. 39:221–234. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin W, Zhou Q, Wang CQ, Zhu L, Bi C, Zhang
S, Wang X and Jin H: LncRNAs regulate metabolism in cancer. Int J
Biol Sci. 16:1194–1206. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fu Y, Liu L, Wu H, Zheng Y, Zhan H and Li
L: LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes
autophagic cell death in NSCLC by targeting UPF1/BRD4 axis. Mol
Cell Biochem. 479:553–566. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou X, Tong Y, Yu C, Pu J, Zhu W, Zhou Y,
Wang Y, Xiong Y and Sun X: FAP positive cancer-associated
fibroblasts promote tumor progression and radioresistance in
esophageal squamous cell carcinoma by transferring exosomal lncRNA
AFAP1-AS1. Mol Carcinog. 63:1922–1937. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hjazi A, Jasim SA, Altalbawy FMA, Kaur H,
Hamzah HF, Kaur I, Deorari M, Kumar A, Elawady A and Fenjan MN:
Relationship between lncRNA MALAT1 and Chemo-radiotherapy
resistance of cancer cells: Uncovered truths. Cell Biochem Biophys.
82:1613–1627. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang H, Jin H, Lei R, He Z, He S, Chen J,
Saw PE, Qiu Z, Ren G and Nie Y: lncRNA-WAL promotes triple-negative
breast cancer aggression by inducing β-catenin nuclear
translocation. Mol Cancer Res. 22:1036–1050. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Russell RC and Guan KL: The multifaceted
role of autophagy in cancer. EMBO J. 41:e1100312022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bhol CS, Senapati PK, Kar RK, Chew G,
Mahapatra KK, Lee EHC, Kumar AP, Bhutia SK and Sethi G: Autophagy
paradox: Genetic and epigenetic control of autophagy in cancer
progression. Cancer Lett. 630:2179092025. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao L, Loveless J, Shay C and Teng Y:
Targeting ROS-Mediated crosstalk between autophagy and apoptosis in
cancer. Adv Exp Med Biol. 1260:1–12. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Carretero-Fernández M, Cabrera-Serrano AJ,
Sánchez-Maldonado JM, Ruiz-Durán L, Jiménez-Romera F,
García-Verdejo FJ, González-Olmedo C, Cardús A, Díaz-Beltrán L,
Gutiérrez-Bautista JF, et al: Autophagy and oxidative stress in
solid tumors: Mechanisms and therapeutic opportunities. Crit Rev
Oncol Hematol. 212:1048202025. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hama Y, Ogasawara Y and Noda NN: Autophagy
and cancer: Basic mechanisms and inhibitor development. Cancer Sci.
114:2699–2708. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Z, Liu F, Li F, Zeng G, Wen X, Ding J
and Zhou J: DHX9-mediated epigenetic silencing of BECN1 contributes
to impaired autophagy and tumor progression in breast cancer via
recruitment of HDAC5. Cell Death Dis. 16:5242025. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cao Z, Tian K, Ran Y, Zhou H, Zhou L, Ding
Y and Tang X: Beclin-1: A therapeutic target at the intersection of
autophagy, immunotherapy, and cancer treatment. Front Immunol.
15:15064262024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li X, Yang KB, Chen W, Mai J, Wu XQ, Sun
T, Wu RY, Jiao L, Li DD, Ji J, et al: CUL3 (cullin 3)-mediated
ubiquitination and degradation of BECN1 (beclin 1) inhibit
autophagy and promote tumor progression. Autophagy. 17:4323–4340.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen X, Sun Y, Wang B and Wang H:
Prognostic significance of autophagy-related genes BECN1 and LC3 in
ovarian cancer: A meta-analysis. J Int Med Res.
48:3000605209682992020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu C, Xu P, Chen D, Fan X, Xu Y, Li M,
Yang X and Wang C: Roles of autophagy-related genes Beclin-1 and
LC3 in the development and progression of prostate cancer and
benign prostatic hyperplasia. Biomed Rep. 1:855–860. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yao Q, Chen J, Lv Y, Wang T, Zhang J, Fan
J and Wang L: The significance of expression of autophagy-related
gene Beclin, Bcl-2, and Bax in breast cancer tissues. Tumour Biol.
32:1163–1171. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu CL, Liu JF, Liu Y, Wang YX, Fu KF, Yu
XJ, Pu Q, Chen XX and Zhou LJ: BECN1 inhibition enhances
paclitaxel-mediated cytotoxicity in breast cancer in vitro and in
vivo. Int J Mol Med. 43:1866–1878. 2019.PubMed/NCBI
|
|
38
|
Tran S, Juliani J, Harris TJ, Evangelista
M, Ratcliffe J, Ellis SL, Baloyan D, Reehorst CM, Nightingale R,
Luk IY, et al: BECN1 is essential for intestinal homeostasis
involving autophagy-independent mechanisms through its function in
endocytic trafficking. Commun Biol. 7:2092024. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ishaq M, Ojha R, Sharma AP and Singh SK:
Autophagy in cancer: Recent advances and future directions. Semin
Cancer Biol Semin Cancer Biol. 66:171–181. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Senapati PK, Mahapatra KK, Singh A and
Bhutia SK: mTOR inhibitors in targeting autophagy and
autophagy-associated signaling for cancer cell death and therapy.
Biochim Biophys Acta Rev Cancer. 1880:1893422025. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ferro F, Servais S, Besson P, Roger S,
Dumas JF and Brisson L: Autophagy and mitophagy in cancer metabolic
remodelling. Semin Cell Dev Biol. 98:129–138. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang M, Liu S, Chua MS, Li H, Luo D, Wang
S, Zhang S, Han B and Sun C: SOCS5 inhibition induces autophagy to
impair metastasis in hepatocellular carcinoma cells via the
PI3K/Akt/mTOR pathway. Cell Death Dis. 10:6122019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Maycotte P, Jones KL, Goodall ML, Thorburn
J and Thorburn A: Autophagy supports breast cancer stem cell
maintenance by regulating IL6 secretion. Mol Cancer Res.
13:651–658. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Song J, Yang P, Chen C, Ding W, Tillement
O, Bai H and Zhang S: Targeting epigenetic regulators as a
promising avenue to overcome cancer therapy resistance. Signal
Transduct Target Ther. 10:2192025. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
ALKhemeiri N, Eljack S and Saber-Ayad MM:
Perspectives of targeting autophagy as an adjuvant to
anti-PD-1/PD-L1 therapy for colorectal cancer treatment. Cells.
14:7452025. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang W, Cheng B, Chen P, Sun X, Wen Z and
Cheng Y: BTN3A1 promotes tumor progression and radiation resistance
in esophageal squamous cell carcinoma by regulating ULK1-mediated
autophagy. Cell Death Dis. 13:9842022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xu Q, Zhang H, Liu H, Han Y, Qiu W and Li
Z: Inhibiting autophagy flux and DNA repair of tumor cells to boost
radiotherapy of orthotopic glioblastoma. Biomaterials.
280:1212872022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chaurasia M, Bhatt AN, Das A, Dwarakanath
BS and Sharma K: Radiation-induced autophagy: Mechanisms and
consequences. Free Radic Res. 50:273–290. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yue T, Zheng D, Yang J, He J and Hou J:
Potential value and cardiovascular risks of programmed cell death
in cancer treatment. Front Pharmacol. 16:16159742025. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu S, Wang L, Zhu L, Zhao T, Han P, Yan
F, Wang X, Li C, Wang Z and Yang BF: Mechanism and regulation of
mitophagy in liver diseases: A review. Front Cell Dev Biol.
13:16149402025. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yun CW and Lee SH: The roles of autophagy
in cancer. Int J Mol Sci. 19:34662018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Singh SS, Vats S, Chia AY, Tan TZ, Deng S,
Ong MS, Arfuso F, Yap CT, Goh BC, Sethi G, et al: Dual role of
autophagy in hallmarks of cancer. Oncogene. 37:1142–1158. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Clark A, Villarreal MR, Huang SB,
Jayamohan S, Rivas P, Hussain SS, Ybarra M, Osmulski P, Gaczynska
ME, Shim EY, et al: Targeting S6K/NFκB/SQSTM1/Polθ signaling to
suppress radiation resistance in prostate cancer. Cancer Lett.
597:2170632024. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sezen Us A, Dagsuyu E, Us H, Cöremen M,
Karabulut Bulan O and Yanardag R: Apocynin may alleviate side
effects of autophagy-blocked radiotherapy through antioxidant
effects. Biotech Histochem. Jun 30–2025.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ma S, Fu X, Liu L, Liu Y, Feng H, Jiang H,
Liu X, Liu R, Liang Z, Li M, et al: Iron-dependent autophagic cell
death induced by radiation in MDA-MB-231 breast cancer cells. Front
Cell Dev Biol. 9:7238012021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Mukha A, Kahya U, Linge A, Chen O, Löck S,
Lukiyanchuk V, Richter S, Alves TC, Peitzsch M, Telychko V, et al:
GLS-driven glutamine catabolism contributes to prostate cancer
radiosensitivity by regulating the redox state, stemness and
ATG5-mediated autophagy. Theranostics. 11:7844–7868. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chen N, Zhang R, Konishi T and Wang J:
Upregulation of NRF2 through autophagy/ERK 1/2 ameliorates ionizing
radiation induced cell death of human osteosarcoma U-2 OS. Mutat
Res Genet Toxicol Environ Mutagen. 813:10–17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wu C, Yang L, Qi X, Wang T, Li M and Xu K:
Inhibition of long non-coding RNA HOTAIR enhances radiosensitivity
via regulating autophagy in pancreatic cancer. Cancer Manag Res.
10:5261–5271. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Cui L, Song Z, Liang B, Jia L, Ma S and
Liu X: Radiation induces autophagic cell death via the p53/DRAM
signaling pathway in breast cancer cells. Oncol Rep. 35:3639–3647.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lei G, Zhang Y, Koppula P, Liu X, Zhang J,
Lin SH, Ajani JA, Xiao Q, Liao Z, Wang H and Gan B: The role of
ferroptosis in ionizing radiation-induced cell death and tumor
suppression. Cell Res. 30:146–162. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Chen X, Kang R, Kroemer G and Tang D:
Broadening horizons: The role of ferroptosis in cancer. Nat Rev
Clin Oncol. 18:280–296. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wang Y, Liu F, Fang C, Xu L, Chen L, Xu Z,
Chen J, Peng W, Fu B and Li Y: Combination of rapamycin and SAHA
enhanced radiosensitization by inducing autophagy and acetylation
in NSCLC. Aging (Albany NY). 13:18223–18237. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Chen J, Luo H, Wu X, Dong M, Wang D, Ou Y,
Wang Y, Sun S, Liu Z, Yang Z, et al: Inhibition of Phosphoglycerate
Kinase 1 Enhances Radiosensitivity of Esophageal Squamous Cell
Carcinoma to X-rays and Carbon Ion Irradiation. Front Biosci
(Landmark Ed). 30:364302025. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Mukha A, Kahya U and Dubrovska A:
Targeting glutamine metabolism and autophagy: The combination for
prostate cancer radiosensitization. Autophagy. 17:3879–3881. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ma X, Mao G, Chang R, Wang F, Zhang X and
Kong Z: Down-regulation of autophagy-associated protein increased
acquired radio-resistance bladder cancer cells sensitivity to
taxol. Int J Radiat Biol. 97:507–516. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Mo N, Lu YK, Xie WM, Liu Y, Zhou WX, Wang
HX, Nong L, Jia YX, Tan AH, Chen Y, et al: Inhibition of autophagy
enhances the radiosensitivity of nasopharyngeal carcinoma by
reducing Rad51 expression. Oncol Rep. 32:1905–1912. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Prise KM and O'Sullivan JM:
Radiation-induced bystander signalling in cancer therapy. Nat Rev
Cancer. 9:351–360. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Jia H, Wei J, Zheng W and Li Z: The dual
role of autophagy in cancer stem cells: Implications for tumor
progression and therapy resistance. J Transl Med. 23:5832025.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zhou S, Wang X, Ding J, Yang H and Xie Y:
Increased ATG5 expression predicts poor prognosis and promotes EMT
in cervical carcinoma. Front Cell Dev Biol. 9:7571842021.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Pustovalova M, Alhaddad L, Blokhina T,
Smetanina N, Chigasova A, Chuprov-Netochin R, Eremin P,
Gilmutdinova I, Osipov AN and Leonov S: The CD44high subpopulation
of multifraction irradiation-surviving NSCLC cells exhibits partial
EMT-program activation and DNA damage response depending on their
p53 Status. Int J Mol Sci. 22:23692021. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Yazal T, Bailleul J, Ruan Y, Sung D, Chu
FI, Palomera D, Dao A, Sehgal A, Gurunathan V, Aryan L, et al:
Radiosensitizing pancreatic cancer via effective autophagy
inhibition. Mol Cancer Ther. 21:79–88. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Gajate C, Gayet O, Fraunhoffer NA, Iovanna
J, Dusetti N and Mollinedo F: Induction of apoptosis in human
pancreatic cancer stem cells by the endoplasmic reticulum-targeted
alkylphospholipid analog edelfosine and potentiation by autophagy
inhibition. Cancers (Basel). 13:61242021. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Fischer P, Schmid M, Ohradanova-Repic A,
Schneeweiss R, Hadatsch J, Grünert O, Benedum J, Röhrer A,
Staudinger F, Schatzlmaier P, et al: Molecular features of TNBC
govern heterogeneity in the response to radiation and autophagy
inhibition. Cell Death Dis. 16:5402025. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Xiao S, Wang Y, Pan S, Mu M, Chen B, Li H,
Feng C, Fan R, Yu W, Han B, et al: Bismuth-functionalized
probiotics for enhanced antitumor radiotherapy and immune
activation. J Mater Chem B. Jul 14–2025.(Epub ahead of print).
View Article : Google Scholar
|
|
76
|
Yang P, Li J, Zhang T, Ren Y, Zhang Q, Liu
R, Li H, Hua J, Wang WA, Wang J and Zhou H: Ionizing
radiation-induced mitophagy promotes ferroptosis by increasing
intracellular free fatty acids. Cell Death Differ. 30:2432–2445.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Liu C, Liu X, Li Z, Wei Y, Liu B, Zhu P,
Liu Y and Zhao R: VPS37A activates the autophagy-lysosomal pathway
for TNFR1 degradation and induces NF-κB-Regulated cell death under
metabolic stress in colorectal cancer. Oncol Res. 33:2085–2105.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Azmat MA, Zaheer M, Shaban M, Arshad S,
Hasan M, Ashraf A, Naeem M, Ahmad A and Munawar N: Autophagy: A new
avenue and biochemical mechanisms to mitigate the climate change.
Scientifica (Cairo). 2024:99083232024. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Choi Y, Bowman JW and Jung JU: Autophagy
during viral infection-a double-edged sword. Nat Rev Microbiol.
16:341–354. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Daniel P, Sabri S, Chaddad A, Meehan B,
Jean-Claude B, Rak J and Abdulkarim BS: Temozolomide induced
hypermutation in glioma: Evolutionary mechanisms and therapeutic
opportunities. Front Oncol. 9:412019. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Liu EK, Sulman EP, Wen PY and Kurz SC:
Novel therapies for glioblastoma. Curr Neurol Neurosci Rep.
20:192020. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Tsai CY, Ko HJ, Huang CF, Lin CY, Chiou
SJ, Su YF, Lieu AS, Loh JK, Kwan AL, Chuang TH and Hong YR:
Ionizing radiation induces resistant glioblastoma stem-like cells
by promoting autophagy via the Wnt/β-catenin pathway. Life (Basel).
11:4512021.PubMed/NCBI
|
|
83
|
Wang Y, Fu Y, Lu Y, Chen S, Zhang J, Liu B
and Yuan Y: Unravelling the complexity of lncRNAs in autophagy to
improve potential cancer therapy. Biochim Biophys Acta Rev Cancer.
1878:1889322023. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zheng J, Mat Ludin AF, Rajab NF, Shaolong
L and Jufri NF: The roles of lncMALAT1 in coronary artery disease
regulation and therapeutic perspective: A systematic review.
iScience. 28:1129452025. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Zhang X, Shi Y, Wang C and Zhang K: LncRNA
MALAT1 knockdown inhibits apoptosis of mouse hippocampus neuron
cells with high glucose by Silencing autophagy. BMC Endocr Disord.
25:1732025. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Yang L, Wang H, Shen Q, Feng L and Jin H:
Long non-coding RNAs involved in autophagy regulation. Cell Death
Dis. 8:e30732017. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Xia N, Zhang P, Yang L, Yin X, Wu SQ, Yao
Y, Shang MY and Weng L: The lncRNA MIR503HG/miR-16-5p/FOSL1 pathway
mediates autophagy to promote esophageal epithelial cells
proliferation and EMT in esophageal restenosis. Arch Biochem
Biophys. 772:1105362025. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zhu X, Sun Y, Yu Q, Wang X, Wang Y and
Zhao Y: Exosomal lncRNA GAS5 promotes M1 macrophage polarization in
allergic rhinitis via restraining mTORC1/ULK1/ATG13-mediated
autophagy and subsequently activating NF-кB signaling. Int
Immunopharmacol. 121:1104502023. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
DeBerardinis RJ, Lum JJ, Hatzivassiliou G
and Thompson CB: The biology of cancer: Metabolic reprogramming
fuels cell growth and proliferation. Cell Metab. 7:11–20. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhou X, Song Y, Wang Z, Fu L, Xu L, Feng
X, Zhang Z and Yuan K: Dietary sugar intervention: A promising
approach for cancer therapy. Biochim Biophys Acta Rev Cancer.
1880:1894022025. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Li C, Wang K, Zhao L, Liu J, Jin Y, Zhang
C, Xu M, Wang M, Kuang Y, Liu J, et al: LINC00622 transcriptionally
promotes RRAGD to repress mTORC1-modulated autophagic cell death by
associating with BTF3 in cutaneous melanoma. Cell Death Dis.
16:5152025. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Wu Q, Ma J, Wei J, Meng W, Wang Y and Shi
M: lncRNA SNHG11 promotes gastric cancer progression by activating
the Wnt/β-Catenin pathway and oncogenic autophagy. Mol Ther.
29:1258–1278. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Chen F, Zhong Z, Tan HY, Guo W, Zhang C,
Cheng CS, Wang N, Ren J and Feng Y: Suppression of lncRNA MALAT1 by
betulinic acid inhibits hepatocellular carcinoma progression by
targeting IAPs via miR-22-3p. Clin Transl Med. 10:e1902020.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Sheng JQ, Wang MR, Fang D, Liu L, Huang
WJ, Tian DA, He XX and Li PY: LncRNA NBR2 inhibits tumorigenesis by
regulating autophagy in hepatocellular carcinoma. Biomed
Pharmacother. 133:1110232021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Wang Z and Jin J: LncRNA SLCO4A1-AS1
promotes colorectal cancer cell proliferation by enhancing
autophagy via miR-508-3p/PARD3 axis. Aging (Albany NY).
11:4876–4889. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Wang Y, Li Z, Xu S, Li W, Chen M, Jiang M
and Fan X: LncRNA FIRRE functions as a tumor promoter by
interaction with PTBP1 to stabilize BECN1 mRNA and facilitate
autophagy. Cell Death Dis. 13:982022. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Lu X, Chen L, Li Y, Huang R, Meng X and
Sun F: Long non-coding RNA LINC01207 promotes cell proliferation
and migration but suppresses apoptosis and autophagy in oral
squamous cell carcinoma by the microRNA-1301-3p/lactate
dehydrogenase isoform A axis. Bioengineered. 12:7780–7793. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Jiang N, Zhang X, Gu X, Li X and Shang L:
Progress in understanding the role of lncRNA in programmed cell
death. Cell Death Discov. 7:302021. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Lu M, Qin X, Zhou Y, Li G, Liu Z, Yue H
and Geng X: LncRNA HOTAIR suppresses cell apoptosis, autophagy and
induces cell proliferation in cholangiocarcinoma by modulating the
miR-204-5p/HMGB1 axis. Biomed Pharmacother. 130:1105662020.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Murakami K, Yokoi Y, Hirane N, Otaki M and
Nishimura SI: Nanosomal irinotecan targeting pancreatic cancer cell
surface neuraminidase-1 sialidase. Adv Healthc Mater. Jul
22–2025.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Wu H, Li A, Zheng Q, Gu J and Zhou W:
LncRNA LZTS1-AS1 induces proliferation, metastasis and inhibits
autophagy of pancreatic cancer cells through the miR-532/TWIST1
signaling pathway. Cancer Cell Int. 23:1302023. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Lv D, Xiang Y, Yang Q, Yao J and Dong Q:
Long Non-Coding RNA TUG1 promotes cell proliferation and inhibits
cell apoptosis, autophagy in clear cell renal cell carcinoma via
MiR-31-5p/FLOT1 axis. Onco Targets Ther. 13:5857–5868. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Shao Q, Wang Q and Wang J: LncRNA SCAMP1
regulates ZEB1/JUN and autophagy to promote pediatric renal cell
carcinoma under oxidative stress via miR-429. Biomed Pharmacother.
120:1094602019. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Zhang Z, Jia JP, Zhang YJ, Liu G, Zhou F
and Zhang BC: Long Noncoding RNA ADAMTS9-AS2 inhibits the
proliferation, migration, and invasion in bladder tumor cells. Onco
Targets Ther. 13:7089–7100. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Li Q, Chen K, Dong R and Lu H: LncRNA
CASC2 inhibits autophagy and promotes apoptosis in non-small cell
lung cancer cells via regulating the miR-214/TRIM16 axis. RSC Adv.
8:40846–40855. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Peng D, Li W, Zhang B and Liu X:
Overexpression of lncRNA SLC26A4-AS1 inhibits papillary thyroid
carcinoma progression through recruiting ETS1 to promote
ITPR1-mediated autophagy. J Cell Mol Med. 25:8148–8158. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Qin Y, Sun W, Wang Z, Dong W, He L, Zhang
T, Lv C and Zhang H: RBM47/SNHG5/FOXO3 axis activates autophagy and
inhibits cell proliferation in papillary thyroid carcinoma. Cell
Death Dis. 13:2702022. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Wang Y, Liu Z, Xu Z, Shao W, Hu D, Zhong H
and Zhang J: Introduction of long non-coding RNAs to regulate
autophagy-associated therapy resistance in cancer. Mol Biol Rep.
49:10761–10773. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Shaw A and Gullerova M: Home and away: The
role of non-coding RNA in intracellular and intercellular DNA
damage response. Genes (Basel). 12:14752021. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Wang S, Qiao C, Fang R, Yang S, Zhao G,
Liu S and Li P: LncRNA CASC19: A novel oncogene involved in human
cancer. Clin Transl Oncol. 25:2841–2851. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Wu Y, Mou J, Zhou G and Yuan C: CASC19: An
oncogenic long non-coding RNA in different cancers. Curr Pharm Des.
30:1157–1166. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Liu H, Zheng W, Chen Q, Zhou Y, Pan Y,
Zhang J, Bai Y and Shao C: lncRNA CASC19 contributes to
radioresistance of nasopharyngeal carcinoma by promoting autophagy
via AMPK-mTOR pathway. Int J Mol Sci. 22:14072021. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Liu H, Chen Q, Zheng W, Zhou Y, Bai Y, Pan
Y, Zhang J and Shao C: LncRNA CASC19 enhances the radioresistance
of nasopharyngeal carcinoma by regulating the miR-340-3p/FKBP5
axis. Int J Mol Sci. 24:30472023. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Wang WJ, Guo CA, Li R, Xu ZP, Yu JP, Ye Y,
Zhao J, Wang J, Wang WA, Zhang A, et al: Long non-coding RNA CASC19
is associated with the progression and prognosis of advanced
gastric cancer. Aging (Albany NY). 11:5829–5847. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Hou Y, Tang Y, Ma C, Yu J and Jia Y:
Overexpression of CASC19 contributes to tumor progression and
predicts poor prognosis after radical resection in hepatocellular
carcinoma. Dig Liver Dis. 55:799–806. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Teng S, Ge J, Yang Y, Cui Z, Min L, Li W,
Yang G, Liu K and Wu J: M1 macrophages deliver CASC19 via exosomes
to inhibit the proliferation and migration of colon cancer cells.
Med Oncol. 41:2862024. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Chiu HS, Somvanshi S, Patel E, Chen TW,
Singh VP, Zorman B, Patil SL, Pan Y, Chatterjee SS; Cancer Genome
Atlas Research Network;, ; et al: Pan-cancer analysis of lncRNA
regulation supports their targeting of cancer genes in each tumor
context. Cell Rep. 23:297–312.e12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Huang Z, Li X, Wang X, Wu J, Gong Z, Kõks
S and Wang M: Nuclear paraspeckle assembly transcript 1 promotes
photophobia behavior in mice via miR-196a-5p/Trpm3 coupling. J
Headache Pain. 26:1182025. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Sakaguchi H, Tsuchiya H, Kitagawa Y,
Tanino T, Yoshida K, Uchida N and Shiota G: NEAT1 Confers
radioresistance to hepatocellular carcinoma cells by inducing
autophagy through GABARAP. Int J Mol Sci. 23:7112022. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Mahmoud HS, Eldesoky NA, Shaker OG and
El-Husseiny AA: The diagnostic value of LncRNA NEAT1 targeting
miR-129-5p in pancreatic cancer patients. Sci Rep. 15:276382025.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Dong P, Xiong Y, Yue J, Xu D, Ihira K,
Konno Y, Kobayashi N, Todo Y and Watari H: Long noncoding RNA NEAT1
drives aggressive endometrial cancer progression via
miR-361-regulated networks involving STAT3 and tumor
microenvironment-related genes. J Exp Clin Cancer Res. 38:2952019.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Almujri SS and Almalki WH: The paradox of
autophagy in cancer: NEAT1′s role in tumorigenesis and therapeutic
resistance. Pathol Res Pract. 262:1555232024. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Wen J, Zheng W, Zeng L, Wang B, Chen D,
Chen Y, Lu X, Shao C, Chen J and Fan M: LTF Induces Radioresistance
by Promoting Autophagy and Forms an AMPK/SP2/NEAT1/miR-214-5p
feedback loop in lung squamous cell carcinoma. Int J Biol Sci.
19:1509–1527. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
He H: Targeting TP53TG1: A promising
prognostic biomarker and therapeutic target for personalized cancer
therapy. Discov Oncol. 16:12712025. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Li J, Liu R, Hu H, Huang Y, Shi Y, Li H,
Chen H, Cai M, Wang N, Yan T, et al: Methionine deprivation
inhibits glioma proliferation and EMT via the
TP53TG1/miR-96-5p/STK17B ceRNA pathway. NPJ Precis Oncol.
8:2702024. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Liao D, Liu X, Yuan X, Feng P, Ouyang Z,
Liu Y and Li C: Long non-coding RNA tumor protein 53 target gene 1
promotes cervical cancer development via regulating microRNA-33a-5p
to target forkhead box K2. Cell Cycle. 21:572–584. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Ji W, Wang W and Wei Y: TP53TG1/STAT axis
is involved in the development of colon cancer through affecting
PD-L1 expression and immune escape mechanism of tumor cells. Am J
Cancer Res. 13:5218–5235. 2023.PubMed/NCBI
|
|
128
|
Cheng Y, Huang N, Yin Q, Cheng C, Chen D,
Gong C, Xiong H, Zhao J, Wang J, Li X, et al: LncRNA TP53TG1 plays
an anti-oncogenic role in cervical cancer by synthetically
regulating transcriptome profile in HeLa cells. Front Genet.
13:9810302022. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Luan F, Chen W, Chen M, Yan J, Chen H, Yu
H, Liu T and Mo L: An autophagy-related long non-coding RNA
signature for glioma. FEBS Open Bio. 9:653–667. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Gao W, Qiao M and Luo K: Long noncoding
RNA TP53TG1 contributes to radioresistance of glioma cells Via
miR-524-5p/RAB5A Axis. Cancer Biother Radiopharm. 36:600–612.
2021.PubMed/NCBI
|
|
131
|
Wang C, Li Y, Yan S, Wang H, Shao X, Xiao
M, Yang B, Qin G, Kong R, Chen R and Zhang N: Interactome analysis
reveals that lncRNA HULC promotes aerobic glycolysis through LDHA
and PKM2. Nat Commun. 11:31622020. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Gandhy SU, Imanirad P, Jin UH, Nair V,
Hedrick E, Cheng Y, Corton JC, Kim K and Safe S: Specificity
protein (Sp) transcription factors and metformin regulate
expression of the long non-coding RNA HULC. Oncotarget.
6:26359–26372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Chen X, Lin J, Liu Y, Peng J, Cao Y, Su Z,
Wang T, Cheng J and Hu D: AlncRNA HULC as an effective biomarker
for surveillance of the outcome of cancer: A meta-analysis. PLoS
One. 12:e01712102017. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Li YP, Liu Y, Xiao LM, Chen LK, Tao EX,
Zeng EM and Xu CH: Induction of cancer cell stemness in glioma
through glycolysis and the long noncoding RNA HULC-activated
FOXM1/AGR2/HIF-1α axis. Lab Invest. 102:691–701. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Li S, Chang M, Tong L, Wang Y, Wang M and
Wang F: Screening potential lncRNA biomarkers for breast cancer and
colorectal cancer combining random walk and logistic matrix
factorization. Front Genet. 13:10236152023. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Chen C, Wang K, Wang Q and Wang X: LncRNA
HULC mediates radioresistance via autophagy in prostate cancer
cells. Braz J Med Biol Res. 51:e70802018. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Hacisuleyman E, Goff LA, Trapnell C,
Williams A, Henao-Mejia J, Sun L, McClanahan P, Hendrickson DG,
Sauvageau M, Kelley DR, et al: Topological organization of
multichromosomal regions by the long intergenic noncoding RNA
Firre. Nat Struct Mol Biol. 21:198–206. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Meng X, Fang E, Zhao X and Feng J:
Identification of prognostic long noncoding RNAs associated with
spontaneous regression of neuroblastoma. Cancer Med. 9:3800–3815.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Shi X, Cui Z, Liu X, Wu S, Wu Y, Fang F
and Zhao H: LncRNA FIRRE is activated by MYC and promotes the
development of diffuse large B-cell lymphoma via Wnt/β-catenin
signaling pathway. Biochem Biophys Res Commun. 510:594–600. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Wang Z, Zhang J, Liu Y, Zhao R, Zhou X and
Wang H: An integrated autophagy-related long noncoding RNA
signature as a prognostic biomarker for human endometrial cancer: A
bioinformatics-based approach. Biomed Res Int. 2020:57174982020.
View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Cai J, Wang R, Chen Y, Zhang C, Fu L and
Fan C: LncRNA FIRRE regulated endometrial cancer radiotherapy
sensitivity via the miR-199b-5p/SIRT1/BECN1 axis-mediated
autophagy. Genomics. 116:1107502024. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Cory S, Graham M, Webb E, Corcoran L and
Adams JM: Variant (6;15) translocations in murine plasmacytomas
involve a chromosome 15 locus at least 72 kb from the c-myc
oncogene. EMBO J. 4:675–681. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Tseng YY, Moriarity BS, Gong W, Akiyama R,
Tiwari A, Kawakami H, Ronning P, Reuland B, Guenther K, Beadnell
TC, et al: PVT1 dependence in cancer with MYC copy-number increase.
Nature. 512:82–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Boloix A, Masanas M, Jiménez C, Antonelli
R, Soriano A, Roma J, Sánchez de Toledo J, Gallego S and Segura MF:
Long Non-coding RNA PVT1 as a prognostic and therapeutic target in
pediatric cancer. Front Oncol. 9:11732019. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Ogunwobi OO and Segura MF: Editorial: PVT1
in cancer. Front Oncol. 10:5887862020. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Lai SW, Chen MY, Bamodu OA, Hsieh MS,
Huang TY, Yeh CT, Lee WH and Cherng YG: Exosomal lncRNA PVT1/VEGFA
axis promotes colon cancer metastasis and stemness by
downregulation of tumor suppressor miR-152-3p. Oxid Med Cell
Longev. 2021:99598072021. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Zhu Y, Wu F, Gui W, Zhang N, Matro E, Zhu
L, Eserberg DT and Lin X: A positive feedback regulatory loop
involving the lncRNA PVT1 and HIF-1α in pancreatic cancer. J Mol
Cell Biol. 13:676–689. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Yao W, Li S, Liu R, Jiang M, Gao L, Lu Y,
Liang X and Zhang H: Long non-coding RNA PVT1: A promising
chemotherapy and radiotherapy sensitizer. Front Oncol.
12:9592082022. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Tan YT, Lin JF, Li T, Li JJ, Xu RH and Ju
HQ: LncRNA-mediated posttranslational modifications and
reprogramming of energy metabolism in cancer. Cancer Commun (Lond).
41:109–120. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Zhou Y, Shao Y, Hu W, Zhang J, Shi Y, Kong
X and Jiang J: A novel long noncoding RNA SP100-AS1 induces
radioresistance of colorectal cancer via sponging miR-622 and
stabilizing ATG3. Cell Death Differ. 30:111–124. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Guo Z, Zhang X, Zhu H, Zhong N, Luo X,
Zhang Y, Tu F, Zhong J, Wang X, He J and Huang L: TELO2 induced
progression of colorectal cancer by binding with RICTOR through
mTORC2. Oncol Rep. 45:523–534. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Chang S, Zhang M, Liu C, Li M, Lou Y and
Tan H: Redox mechanism of glycerophospholipids and relevant
targeted therapy in ferroptosis. Cell Death Discov. 11:3582025.
View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Zhang L, Yu S, Wang C, Jia C, Lu Z and
Chen J: Establishment of a non-coding RNAomics screening platform
for the regulation of KRAS in pancreatic cancer by RNA sequencing.
Int J Oncol. 53:2659–2670. 2018.PubMed/NCBI
|
|
154
|
Muthoni A, Anyango A and V Wanjala H:
Mucilage-based nanocarriers for targeted cancer therapy-design,
functionalization, and therapeutic potential. Drug Dev Ind Pharm.
Aug 4–2025.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Wu T and Du Y: LncRNAs: From basic
research to medical application. Int J Biol Sci. 13:295–307. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Zhang L, Chen H, Yang Y, Zhao L, Xie H, Li
P, Lv X, He L, Liu N and Liu B: Targeting LINC02320 prevents
colorectal cancer growth via GRB7-dependent inhibition of MAPK
signaling pathway. Cell Mol Biol Lett. 30:862025. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Taylor MA, Das BC and Ray SK: Targeting
autophagy for combating chemoresistance and radioresistance in
glioblastoma. Apoptosis. 23:563–575. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Han F, Chen S, Zhang K, Zhang K, Wang M
and Wang P: Targeting the HNRNPA2B1/HDGF/PTN axis to overcome
radioresistance in non-small cell lung cancer. Antioxid Redox
Signal. 43:189–214. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Liu Y, Chen X, Chen X, Liu J, Gu H, Fan R
and Ge H: Long non-coding RNA HOTAIR knockdown enhances
radiosensitivity through regulating microRNA-93/ATG12 axis in
colorectal cancer. Cell Death Dis. 11:1752020. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Yan Y, Chen X, Wang X, Zhao Z, Hu W, Zeng
S, Wei J, Yang X, Qian L, Zhou S, et al: The effects and the
mechanisms of autophagy on the cancer-associated fibroblasts in
cancer. J Exp Clin Cancer Res. 38:1712019. View Article : Google Scholar : PubMed/NCBI
|
